ClinConnect ClinConnect Logo
Search / Trial NCT06363890

Etiology of Travelers' Diarrhea in Australian Tourists Traveling to Southeast Asia

Launched by LUMEN BIOSCIENCE, INC. · Apr 9, 2024

Trial Information

Current as of September 07, 2025

Recruiting

Keywords

Travelers Diarrhea Australian Epidemiology

ClinConnect Summary

This clinical trial is looking at the causes and frequency of diarrhea among Australian tourists traveling to Southeast Asia. The study will focus on adults who are planning to visit countries like Cambodia, Indonesia, and Thailand for 14 to 28 days. By understanding more about travelers' diarrhea, the researchers hope to improve treatments and preventive measures for future travelers.

To join the study, participants need to be at least 18 years old, currently living in Australia, and have a trip planned to one of the selected Southeast Asian countries within the next month. They should also be willing to complete all study activities, which will continue for about 28 days after their trip. It's important that participants have access to a smartphone and mobile service while traveling so they can stay connected throughout the study. If someone is interested, they will need to give their permission to take part in the research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult aged \> 18 years residing in Australia.
  • Planned travel for 14 to 28 days starting in the next 30 days to selected countries in Southeast Asia, including Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Thailand, Timor-Leste, and Vietnam.
  • Willing to participate in the clinical study and available for all planned study activities through approximately 28 days post-travel.
  • Access to a smartphone and mobile phone services while traveling (either by local SIM card, WiFi, or international roaming service on the individual's home-country mobile phone).
  • Exclusion Criteria:
  • Unable or unwilling to provide adequate informed consent.

About Lumen Bioscience, Inc.

Lumen Bioscience, Inc. is an innovative biotechnology company specializing in the development of therapeutic and diagnostic solutions leveraging its proprietary platform for producing biologics in engineered algae. Focused on addressing significant unmet medical needs, Lumen Bioscience harnesses the unique properties of microalgae to create safe and effective treatments, particularly in the fields of gastrointestinal diseases and infectious agents. Committed to advancing patient care through rigorous research and clinical trials, the company aims to transform the landscape of biopharmaceuticals with its sustainable and scalable production methods.

Locations

Melbourne, , Australia

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported